Publications by authors named "Nik Ding"

Claim this Profile
E
Early Infliximab Levels and Clearance Predict Outcomes After Infliximab Rescue in Acute Severe Ulcerative Colitis: Results From PREDICT-UC.
Christopher F D Li Wai Suen, Matthew C Choy, Danny Con, Kaylene Cheng, Julie Nigro, Nik S Ding

Gastroenterology· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Managing the Moving Target-Dose Adjustments in Inflammatory Bowel Disease.
Nicholas Clark, Daniel Tassone, Nik Sheng Ding

Aliment Pharmacol Ther· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Australian Real-World Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Results of the AURORA Study, Including the ANZIBD Consortium.
Yoon-Kyo An, Niamh Lindsay, Natalie Allan, Emi Khoo, Richard Fernandes, Nik S Ding

JGH Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upadacitinib induction is effective and safe in ulcerative colitis patients including those with prior exposure to tofacitinib: a multicenter real-world cohort study.
Robert Gilmore, Richard Fernandes, Imogen Hartley, Arteen Arzivian, Rupert Leong, Nik Ding

Intest Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infliximab-Induced Immune Thrombocytopenic Purpura in an Ulcerative Colitis Patient.
Mark Lai, Timothy Phan, Ola Niewiadomski, Nik Ding

Case Rep Gastroenterol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perianal Fistulizing Crohn's Disease: Utilizing the TOpClass Classification in Clinical Practice to Provide Targeted Individualized Care.
Luke N Hanna, Sulak Anandabaskaran, Nusrat Iqbal, Jeroen Geldof, Jean-Frédéric LeBlanc, Nik S Ding

Clin Gastroenterol Hepatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Fecal Diversion in Perianal Crohn's Disease: A Systematic Review and Meta-Analysis.
Imogen Hartley, Babak Sarraf, Helen Wilding, Jonathan P Segal, Nik Sheng Ding

J Dig Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRI assessment of body composition for prediction of therapeutic response to biologic agents in patients with Crohn's disease.
Naomi S Sakai, Andrew A Plumb, Norin Ahmed, Kashfia Chowdhury, Yakup Kilic, Nik Ding

Insights Imaging· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Where to Start in Ulcerative Colitis?
Tanya Lee, Nik Ding, John David Chetwood

Aliment Pharmacol Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Perianal Fistulizing Crohn's Disease According to Principles of Wound Repair.
Jeffrey D McCurdy, Imogen Hartley, Corina Behrenbruch, Ailsa Hart, Phil Tozer, Nik S Ding

Aliment Pharmacol Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter: Bowel Preparation Quality in Patients With Crohn's Disease.
Tamar Schildkraut, Nik John S Ding, John David Chetwood

Aliment Pharmacol Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new protocolized treatment strategy optimizing medical and surgical care leads to improved healing of Crohn's perianal fistulas.
Michael De Gregorio, Leon S Winata, Imogen Hartley, Corina C Behrenbruch, Susan J Connor, Nik S Ding

J Crohns Colitis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6-Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapy.
Natalie Yu, Tanya Lee, Daniel Tassone, Sara Vogrin, Steven Phan, Nik S Ding

Intern Med J· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial.
Matthew C Choy, Christopher F D Li Wai Suen, Danny Con, Kristy Boyd, Raquel Pena, Nik S Ding

Lancet Gastroenterol Hepatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter: Ulcerative proctitis-A step towards addressing the knowledge gap, and a call for greater detail, in trial data.
John David Chetwood, Nik Sheng Ding

Aliment Pharmacol Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review and meta-analysis of endoscopic versus medical management of peptic ulcers with adherent clots.
Daniel Tassone, Shamsul Kazi, Tanya Lee, Robert Gilmore, Nik Ding

J Gastroenterol Hepatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of a Comprehensive Specialist Inflammatory Bowel Disease Nursing Service.
Natalie Yu, Kyle Wu, Tamie Samyue, Stephanie Fry, Annalise Stanley, Nik S Ding

Inflamm Bowel Dis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update for surgeons on novel induction treatments for acute severe inflammatory bowel disease associated colitis.
Timothy Levar, Michael Johnston, Nik S Ding, Corina Behrenbruch

ANZ J Surg· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The aetiology of pouchitis in patients with inflammatory bowel disease.
Maram Alenzi, Tamar Schildkraut, Imogen Hartley, Sarit Badiani, Nik Sheng Ding

Therap Adv Gastroenterol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: The prevalence and outcomes of perianal Crohn's disease across treatment eras.
Daniel Tassone, Imogen Hartley, Nik Sheng Ding

Aliment Pharmacol Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferred definitive surgical management of Crohn's perianal fistulas and factors influencing surgical decision making in Australia and New Zealand.
Michael De Gregorio, Ankur Sidhu, Cori Behrenbruch, Susan J Connor, Glen Guerra, Nik S Ding

ANZ J Surg· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of NUDT15 Genetic Variants and Incidence of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Natalie Yu, Danujan Sriranganathan, Gareth J Walker, Aleksejs Sazonovs, Helen Wilding, Nik S Ding

J Crohns Colitis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter: Muscle thickness measurement using ultrasound-A step closer to the use of body composition analysis in the management of inflammatory bowel disease.
Daniel Tassone, Imogen Hartley, Nik Sheng Ding

Aliment Pharmacol Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter: Combatting sarcopenia to improve clinical outcomes in inflammatory bowel disease.
Daniel Tassone, Imogen Hartley, Nik Sheng Ding

Aliment Pharmacol Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vedolizumab for induction and maintenance of remission in Crohn's disease.
Samuel Hui, Vassiliki Sinopoulou, Morris Gordon, Ghazaleh Aali, Anuj Krishna, Nik Sheng Ding

Cochrane Database Syst Rev· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis